AU2001266534A1 - Papillomavirus vaccine - Google Patents
Papillomavirus vaccineInfo
- Publication number
- AU2001266534A1 AU2001266534A1 AU2001266534A AU6653401A AU2001266534A1 AU 2001266534 A1 AU2001266534 A1 AU 2001266534A1 AU 2001266534 A AU2001266534 A AU 2001266534A AU 6653401 A AU6653401 A AU 6653401A AU 2001266534 A1 AU2001266534 A1 AU 2001266534A1
- Authority
- AU
- Australia
- Prior art keywords
- papillomavirus vaccine
- papillomavirus
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0002498A SE0002498D0 (en) | 2000-07-03 | 2000-07-03 | Papillomavirus vaccine |
| SE0002498 | 2000-07-03 | ||
| PCT/SE2001/001501 WO2002002142A1 (en) | 2000-07-03 | 2001-06-29 | Papillomavirus vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001266534A1 true AU2001266534A1 (en) | 2002-01-14 |
Family
ID=20280346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001266534A Abandoned AU2001266534A1 (en) | 2000-07-03 | 2001-06-29 | Papillomavirus vaccine |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2001266534A1 (en) |
| SE (1) | SE0002498D0 (en) |
| WO (1) | WO2002002142A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200101445T2 (en) | 1998-11-27 | 2001-10-22 | Akzo Nobel N.V. | Stable, attenuated rabies virus mutants and live vaccines of these mutants |
| DE102008010954A1 (en) * | 2008-02-25 | 2009-08-27 | Cichon, Günter, Prof.Dr. | DNA vaccine for the therapy and prophylaxis of cervical cancer and its premalignant precursors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL113817A (en) * | 1994-06-30 | 2001-03-19 | Merck & Co Inc | Polynucleotide vaccne for papillomavirus |
-
2000
- 2000-07-03 SE SE0002498A patent/SE0002498D0/en unknown
-
2001
- 2001-06-29 AU AU2001266534A patent/AU2001266534A1/en not_active Abandoned
- 2001-06-29 WO PCT/SE2001/001501 patent/WO2002002142A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002142A1 (en) | 2002-01-10 |
| WO2002002142B1 (en) | 2002-03-21 |
| SE0002498D0 (en) | 2000-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002336760A1 (en) | Mutable vaccines | |
| SI1410805T1 (en) | Vaccine against HPV | |
| AU2002236159A1 (en) | Immunogenic complex | |
| AU2001240109A1 (en) | Dna vaccines against poxviruses | |
| AU2002254558A1 (en) | Novel vaccine | |
| AU2001258279A1 (en) | Adjuvant for vaccines | |
| AU2003301850A1 (en) | Hiv vaccine | |
| AU5977700A (en) | Vaccines | |
| AU1600401A (en) | Malaria vaccine | |
| AU2001275723A1 (en) | Bougie | |
| AU6158700A (en) | Vaccine | |
| AUPR030800A0 (en) | Immunomodulatory preparation | |
| AU2002236065A1 (en) | Papillomavirus vaccines | |
| AU2002249823A1 (en) | Acne vaccine | |
| AU2001267541A1 (en) | Vaccine composition | |
| AU2002224845A1 (en) | Viral expression system | |
| AU5811600A (en) | Vaccine | |
| AU2002222139A1 (en) | Hcv vaccines | |
| AU2001266534A1 (en) | Papillomavirus vaccine | |
| AU4957800A (en) | Vaccine against isa virus | |
| AU2002219846A1 (en) | Novel use | |
| AU2000279374A1 (en) | Secure syringe | |
| AU2002303093A1 (en) | Mycobacterial vaccines | |
| AU5084300A (en) | New vaccine formulations - 1 | |
| AU2001285421A1 (en) | Vaccine against rsv |